Second batch of Sputnik V Vaccine reaches

60,000 doses of Russia’s C-19 vaccine Sputnik V landed at Rajiv Gandhi International Airport here, Dr Reddy’s Laboratories said.

“Pleased to share that the consignment that arrived today in Hyderabad contains 60,000 doses of the second dose component of the Sputnik V vaccine. Samples from the consignment will be sent for release to the Central Drugs Laboratory (CDL),” the company tweeted.

On May 14, Dr Reddy’s Laboratories soft-launched the Sputnik V vaccine which is priced at Rs 948, with five per cent GST per dose (retail price).

“Given the recent launch of the Russian vaccine in the Indian vaccination campaign, this second delivery has become very timely. The efficacy of the Sputnik V is well-known in the world,” Nikolay Kudashev Russian Ambassador to India tweeted.

The first consignment of 1.50 lakh doses of Sputnik V vaccine from the Russian Direct Investment Fund (RDIF) landed in India on May 1, and received regulatory clearance from the Central Drugs Laboratory.

Dr Reddy’s had earlier said these consignments will be used across different channels as a pilot to line up the supply chain for the larger vaccination programme rollout.

Related Posts

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

The Team Meticulously averted the Risk of Thrombosis, Husband was Donor Delhi/NCR : Doctors at Yashoda Medicity have successfully performed a high-risk kidney transplant in a 28-year-old woman with Antiphospholipid…

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta, a UK-based clinical stage biotech, is differentiated clinical-stage oncology specialist, increasingly defined by continuing progress with its second-generation pre|CISION tumour-activated Peptide Drug Conjugate (PDC) platform. The lead Gen Two…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Yashoda Medicity Successfully Performs High-Risk Kidney Transplant in 28-Year- Old Woman

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

Avacta delivers two clinical stage peptide-drug conjugates to target delivery of toxic payloads into the tumour microenvironment

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

US FDA approves first gene therapy for paediatric patients with Sanfilippo syndrome type A

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Technology and accessibility are key to growth of advanced treatment of heart diseases, says expert

Puresta launches EVERQ, AI-powered skin-health platform

Puresta launches EVERQ, AI-powered skin-health platform

Stem cell therapy for autism only in approved clinical trials: Centre

Stem cell therapy for autism only in approved clinical trials: Centre